{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:17:33Z","timestamp":1761895053958,"version":"3.37.3"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/mjt.0b013e31818e30da","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T08:15:25Z","timestamp":1269418525000},"page":"596-603","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of Obesity With \u201cCombination\u201d Pharmacotherapy"],"prefix":"10.1097","volume":"17","author":[{"given":"Richard B","family":"Rothman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210202","first-page":"985","article-title":"States, 2005.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-12-20210202","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1053\/j.gastro.2007.03.052","article-title":"The epidemiology of obesity.","volume":"132","author":"Ogden","year":"2007","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"R3-12-20210202","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jada.2005.02.018","article-title":"Beyond energy balance: there is more to obesity than kilocalories.","volume":"105","author":"Bray","year":"2005","journal-title":"J Am Diet Assoc"},{"key":"R4-12-20210202","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/oby.2003.102","article-title":"A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity.","volume":"11","author":"Bray","year":"2003","journal-title":"Obes Res"},{"key":"R5-12-20210202","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.ijo.0802741","article-title":"Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study.","volume":"28","author":"Marchesini","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R6-12-20210202","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/13548500600621545","article-title":"Effects of diets and their role in weight control.","volume":"12","author":"Amigo","year":"2007","journal-title":"Psychol Health Med"},{"key":"R7-12-20210202","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa050156","article-title":"Randomized trial of lifestyle modification and pharmacotherapy for obesity.","volume":"353","author":"Wadden","year":"2005","journal-title":"N Engl J Med"},{"key":"R8-12-20210202","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1053\/j.gastro.2007.03.053","article-title":"Drug treatment of the overweight patient.","volume":"132","author":"Bray","year":"2007","journal-title":"Gastroenterology"},{"key":"R9-12-20210202","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1517\/13543784.15.3.257","article-title":"The potential use of selective 5-HT2C agonists in treating obesity.","volume":"15","author":"Smith","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"issue":"Suppl","key":"R10-12-20210202","doi-asserted-by":"crossref","first-page":"163S","DOI":"10.1038\/oby.2004.283","article-title":"Long-term pharmacotherapy for obesity.","volume":"12","author":"Klein","year":"2004","journal-title":"Obes Res"},{"key":"R11-12-20210202","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.clinpsy.2.022305.095249","article-title":"Obesity.","volume":"2","author":"Fabricatore","year":"2006","journal-title":"AnnuRev Clin Psychol"},{"key":"R12-12-20210202","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nature05026","article-title":"Central nervous system control of food intake and body weight.","volume":"443","author":"Morton","year":"2006","journal-title":"Nature"},{"key":"R13-12-20210202","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jada.2005.03.010","article-title":"Medications as adjunct therapy for weight loss: approved and off-label agents in use.","volume":"105","author":"Moyers","year":"2005","journal-title":"J Am Diet Assoc"},{"key":"R14-12-20210202","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.","volume":"353","author":"Despres","year":"2005","journal-title":"N Engl J Med"},{"key":"R15-12-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","article-title":"Sibutramine produces dose-related weight loss.","volume":"7","author":"Bray","year":"1999","journal-title":"Obes Res"},{"key":"R16-12-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1037\/0022-006X.65.1.79","article-title":"What is a reasonable weight loss? Patients expectations and evaluations of obesity treatment outcomes.","volume":"65","author":"Foster","year":"1997","journal-title":"J Consult Clin Psychol"},{"key":"R17-12-20210202","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/clpt.1992.76","article-title":"Long-term weight control study: conclusions.","volume":"51","author":"Weintraub","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"R18-12-20210202","first-page":"A561","article-title":"Comparison of Serotonin Agonists in Combination With Phentermine for Treatment of Obesity.","volume":"10","author":"Dhurandhar","year":"1996","journal-title":"FASEB J"},{"key":"R19-12-20210202","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/j.1550-8528.1997.tb00579.x","article-title":"Long-term drug treatment of obesity in a private practice setting.","volume":"5","author":"Atkinson","year":"1997","journal-title":"Obes Res"},{"key":"R20-12-20210202","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/j.1550-8528.1999.tb00414.x","article-title":"Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.","volume":"7","author":"Ryan","year":"1999","journal-title":"Obes Res"},{"key":"R21-12-20210202","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2337\/diacare.22.6.896","article-title":"Pharmacologic induction of weight loss to treat type 2 diabetes.","volume":"22","author":"Redmon","year":"1999","journal-title":"Diabetes Care"},{"key":"R22-12-20210202","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"R23-12-20210202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine.","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"R25-12-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01061381","article-title":"Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors.","volume":"23","author":"Magnussen","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 4","key":"R27-12-20210202","doi-asserted-by":"crossref","first-page":"S477","DOI":"10.1002\/j.1550-8528.1995.tb00215.x","article-title":"Brain serotonin, carbohydrate-craving, obesity and depression.","volume":"3","author":"Wurtman","year":"1995","journal-title":"Obes Res"},{"key":"R28-12-20210202","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pharmthera.2005.06.004","article-title":"Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.","volume":"109","author":"Turner","year":"2006","journal-title":"Pharmacol Ther"},{"key":"R29-12-20210202","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0165-1781(82)90074-9","article-title":"Kinetics of L-5-hydroxytryptophan in healthy subjects.","volume":"7","author":"Westenberg","year":"1982","journal-title":"Psychiatry Res"},{"key":"R30-12-20210202","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/BF02532418","article-title":"Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme.","volume":"21","author":"Berry","year":"1996","journal-title":"Neurochem Res"},{"key":"R31-12-20210202","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0306-3623(94)00223-A","article-title":"Aromatic L-amino acid decarboxylase: biological characterization and functional role.","volume":"26","author":"Zhu","year":"1995","journal-title":"Gen Pharmacol"},{"key":"R32-12-20210202","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1124\/jpet.106.101618","article-title":"Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.","volume":"318","author":"Zolkowska","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"R33-12-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.CIR.99.1.156","article-title":"Aminorex to fen\/phen: an epidemic foretold.","volume":"99","author":"Fishman","year":"1999","journal-title":"Circulation"},{"key":"R34-12-20210202","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2125.1995.tb04456.x","article-title":"Blood and urine 5-hydroxytryptophan and 5-hydroxytryptamine levels after administration of two 5-hydroxytryptamine precursors in normal man.","volume":"39","author":"Li Kam Wa","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"R35-12-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2003.10.011","article-title":"5-Hydroxy-L-tryptophan suppresses food intake in food-deprived and stressed rats.","volume":"77","author":"Amer","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"R36-12-20210202","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/sj.ijo.0800642","article-title":"Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients.","volume":"22","author":"Cangiano","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R37-12-20210202","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/ajcn\/56.5.863","article-title":"Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan.","volume":"56","author":"Cangiano","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"R38-12-20210202","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000118469","article-title":"L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression.","volume":"20","author":"Zmilacher","year":"1988","journal-title":"Neuropsychobiology"},{"key":"R39-12-20210202","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.toxlet.2003.12.070","article-title":"Safety of 5-hydroxy-L-tryptophan.","volume":"150","author":"Das","year":"2004","journal-title":"Toxicol Lett"},{"key":"R40-12-20210202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004714-198706000-00002","article-title":"5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects.","volume":"7","author":"Byerley","year":"1987","journal-title":"J Clin Psychopharmacol"},{"key":"R41-12-20210202","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0773.1984.tb02037.x","article-title":"Effects of carbidopa on the cerebral accumulation of exogenous L-5-hydroxytryptophan in mice.","volume":"55","author":"Magnussen","year":"1984","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"R42-12-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004714-200204000-00012","article-title":"Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers.","volume":"22","author":"Gijsman","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"R43-12-20210202","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","article-title":"Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.","volume":"92","author":"Robiolio","year":"1995","journal-title":"Circulation"},{"key":"R44-12-20210202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF00445552","article-title":"Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium.","volume":"99","author":"Artigas","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"R45-12-20210202","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004714-199210000-00003","article-title":"Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.","volume":"12","author":"Celada","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"R46-12-20210202","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1378\/chest.117.3.870","article-title":"Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension.","volume":"117","author":"Rich","year":"2000","journal-title":"Chest"},{"key":"R47-12-20210202","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2125.1999.00928.x","article-title":"Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke.","volume":"47","author":"Derby","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"R48-12-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"R49-12-20210202","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/syn.20126","article-title":"Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis.","volume":"56","author":"Alexander","year":"2005","journal-title":"Synapse"},{"key":"R50-12-20210202","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tips.2006.10.006","article-title":"Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction.","volume":"27","author":"Rothman","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"R51-12-20210202","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.clpt.6100163","article-title":"New targets for obesity pharmacotherapy.","volume":"81","author":"Aronne","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R52-12-20210202","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/sj.clpt.6100161","article-title":"Challenges in the discovery and development of new agents for the treatment of obesity.","volume":"81","author":"Staten","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R53-12-20210202","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.clpt.6100169","article-title":"Obesity pharmacotherapy from a regulatory perspective: overview and key challenges.","volume":"81","author":"Hutchinson","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"R54-12-20210202","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1524-6175.2007.08134.x","article-title":"Risk-based classification of hypertension and the role of combination therapy.","volume":"10","author":"Weir","year":"2008","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R55-12-20210202","first-page":"665","article-title":"Optimizing combination treatment in the management of type 2 diabetes.","volume":"3","author":"Derosa","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"R56-12-20210202","first-page":"33","article-title":"Beneficial effect of combination therapy with antihypertensive drugs in patients with hypertension.","volume":"12","author":"Shikata","year":"2007","journal-title":"Exp Clin Cardiol"},{"key":"R57-12-20210202","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archinte.1984.00350180055008","article-title":"A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.","volume":"144","author":"Weintraub","year":"1984","journal-title":"Arch Intern Med"},{"key":"R58-12-20210202","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0893-133X(95)00113-R","article-title":"Evaluation of phentermine and fenfluramine, alone and in combination, in normal, healthy volunteers.","volume":"14","author":"Brauer","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"R59-12-20210202","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1196\/annals.1369.064","article-title":"Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs.","volume":"1074","author":"Rothman","year":"2006","journal-title":"Ann N Y Acad Sci"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e31818e30da","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:37:45Z","timestamp":1739986665000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201011000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e31818e30da","relation":{},"ISSN":["1075-2765"],"issn-type":[{"type":"print","value":"1075-2765"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}